Connect with us

Business

Electric car sales hit record high in September

Published

on

Electric car sales hit record high in September


Electric vehicle (EV) sales in the UK hit a record high last month, according to the latest industry figures.

Sales of pure battery electric vehicles (BEV) grew by almost a third to 72,779 in September, according to the Society of Motor Manufacturers (SMMT), while sales of plug-in hybrid cars grew even faster.

It means sales of fully electric or hybrid vehicles made up more than half of all new car registrations in the UK last month.

The SMMT said sales were driven by carmakers offering discounts, a larger choice of models, and the introduction of the government’s grant scheme.

While registrations of BEVs rose last month, the overwhelming majority – 71.4% – were bought by businesses or to be used in fleets.

However, the number of private buyers of fully electric cars has risen in the past year, and the SMMT said zero-emission vehicles now accounted for more than one in five (22.1%) new cars registered so far in 2025.

SMMT chief executive Mike Hawes said electrified vehicles were “powering market growth after a sluggish summer”.

Industry investment in electric vehicles was “paying off”, he said, despite consumer demand “trailing ambition”.

Mr Hawes added the government’s electric car grant scheme, in which eligible vehicles get a discount of up to £3,750 as part of efforts to encourage drivers to move away from petrol and diesel vehicles, would help “break down one of the barriers” holding back people making the switch.

Overall, the number of new vehicle registrations – 312,887 – marked the best performing September since 2020, which despite the Covid lockdown restrictions, remains the best so far this decade, according to the SMMT.

The strong month comes as the UK car industry navigates the economic impact of US tariffs and Jaguar Land Rover’s shutdown of production due to a major cyber-attack.

The Kia Sportage, Ford Puma and Nissan Qashqai were the best-selling cars in September, but two Chinese models including the Jaecoo 7 and BYD Seal U were in the top 10.

The government said more than 20,000 people had benefited from EV grants to date, which apply to models from several well-known brands such as Ford, Toyota, Vauxhall and Citroen.

Under the scheme, the discount applies to new eligible car models costing up to £37,000, with the most environmentally friendly ones seeing the biggest reductions. Some 36 models have been cleared for discounts of at least £1,500.

Ian Plummer, Autotrader’s chief commercial officer, said the grant scheme had given a “real lift to the market”.

“Since July, enquiries for new electric vehicles on Autotrader are up by almost 50%. For models eligible for the grant, interest has more than doubled.”



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site

Published

on

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site


The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025.

Mike Blake | Reuters

Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect, building on efforts by the company and the Trump administration to make the medicine more accessible.

The announcement also comes weeks after chief rival Novo Nordisk unveiled additional discounts on the cash prices of its obesity and diabetes drugs. 

Starting Monday, cash-paying patients with a valid prescription can get the starting dose of Zepbound vials for as low as $299 per month on LillyDirect, down from a previous price of $349 per month. They can also access the next dose, 5 milligrams, for $399 per month and all other doses for $449 per month, down from $499 per month across those sizes. 

Zepbound carries a list price of roughly $1,086 per month. That price point, and spotty insurance coverage for weight loss drugs in the U.S., have been significant barriers to access for some patients. 

Eli Lilly’s announcement comes just weeks after President Donald Trump inked deals with Eli Lilly and Novo Nordisk to make their GLP-1 drugs easier for Americans to get and afford. The agreements will cut the prices the government pays for the drugs, introduce Medicare coverage of obesity drugs for the first time for certain patients and offer discounted medicines on the government’s new direct-to-consumer website launching in January, TrumpRx. 

But Eli Lilly’s deal with Trump centers around lowering the prices of a different form of Zepbound – a multi-dose pen – after it wins Food and Drug Administration approval. 

That means Eli Lilly’s Monday announcement around cutting prices on the existing single-dose vials could allow more patients to get discounted treatments more quickly. 

“We will keep working to provide more options — expanding choices for delivery devices and creating new pathways for access — so more people can get the medicines they need,” said Ilya Yuffa, president of Lilly USA and global customer capabilities, in a statement. 

Eli Lilly’s stock, which has climbed more than 36% this year, fell nearly 2% on Monday. Its meteoric rise due to the success of Zepbound and its diabetes injection Mounjaro vaulted it to becoming the first health-care company to hit a $1 trillion market value last month. Though cutting prices means lower revenue per medication sold, Eli Lilly’s sales — and shares — have continued to soar through past pricing announcements as demand balloons.

With single-dose vials, patients need to use a syringe and needle to draw up the medicine and inject it into themselves. Eli Lilly first introduced that form of Zepbound in August 2024. 

It’s unclear how many patients are currently using single-dose vials of Zepbound. But Eli Lilly previously said that direct-to-consumer sales now account for more than a third of new prescriptions of Zepbound. 

Novo Nordisk earlier this month lowered the price of its obesity drug Wegovy and diabetes treatment Ozempic for existing cash-paying patients to $349 per month from $499 per month. That excludes the highest dose of Ozempic. 

The company also launched a temporary introductory offer, which will allow new cash-paying patients to access the two lowest doses of Wegovy and Ozempic for $199 per month for the first two months of treatment. 



Source link

Continue Reading

Business

OBR chairman resigns over Budget leak

Published

on

OBR chairman resigns over Budget leak



The chairman of the Office for Budget Responsibility (OBR) has resigned over the early publication of the watchdog’s forecasts.

Richard Hughes said he was resigning to allow the OBR to “quickly move on from this regrettable incident”.

His resignation follows publication of a report that described the leak as “the worst failure in the 15-year history of the OBR” and strongly criticised the watchdog’s processes for protecting sensitive information.

In a letter to the Chancellor and the chairwoman of the Commons Treasury Committee, Mr Hughes said he took “full responsibility” for “the shortcomings identified in the report”.

He said: “By implementing the recommendations in this report, I am certain the OBR can quickly regain and restore the confidence and esteem that it has earned through 15 years of rigorous, independent economic analysis.”

Mr Hughes has served as chairman of the OBR since 2020 and was reappointed to the job for a second five-year term in July this year.

Speaking in the Commons as the news of the resignation broke, Chief Secretary to the Treasury James Murray offered the Government’s thanks to Mr Hughes “for his dedication to public service”.

Later, the Chancellor herself offered her thanks for Mr Hughes’ “many years of public service”, adding: “This Government is committed to protecting the independence of the OBR and the integrity of our fiscal framework and institutions.”

Conservative leader Kemi Badenoch accused the Chancellor of using Mr Hughes as a “human shield” and called on Rachel Reeves to resign.

Liberal Democrat Treasury spokeswoman Daisy Cooper said Mr Hughes was “a dedicated public servant” who had “rightly taken responsibility for a failure on his watch”, adding the OBR needed to learn from its “catastrophic error”.

Treasury Committee chairwoman Dame Meg Hillier also thanked Mr Hughes, saying: “I commend his decision to take full responsibility for the incident and I wish him well for the future.”

The Treasury said it would begin the process of finding a replacement for Mr Hughes “in the coming weeks”.

The OBR launched an investigation after official forecasts were uploaded to the watchdog’s website, releasing details of the Budget almost an hour early.

In a report published on Monday, the OBR said the leak had been “seriously disruptive to the Chancellor, who had every right to expect that the (forecasts) would not be publicly available until she sat down at the end of her Budget speech”.

Noting Mr Hughes had already “rightly” apologised for the leak, the report said it was “not a case of intentional leakage” or a matter of pressing publish too early.

The OBR said it was caused by two errors linked to the WordPress publishing site it used.

The report into the incident said that, while it knew web addresses for its files follow a pattern, it assumed “the protections provided” by WordPress “would ensure it could not be accessed”.

But two configuration errors were the technical causes of the premature access.

The forecast for the last spring statement in March was also “accessed prematurely” on one occasion, the report noted, but concluded that no activity appeared to have been taken as a result and the most likely explanation is “benign”.

The report recommended a review of the watchdog’s processes for publishing such documents.

“To rebuild trust, the leadership of the OBR must take immediate steps to change completely the publication arrangements for the two important and time-sensitive documents containing the results of its biannual forecasts that it publishes in a normal year, and review arrangements for all other publications,” the report said.

One option would be for the watchdog to use the Government’s digital architecture but publish when it wants.

Another would be to have the Treasury publish the forecasts for the Budget and spring statement, but this would only work if safeguards for “real and perceived independence” could be put in place.

There may need to be an interim solution, the report noted, but said new arrangements must be in place in time for the next statement in spring 2026.



Source link

Continue Reading

Business

OGRA Announces LPG Price Increase for December – SUCH TV

Published

on

OGRA Announces LPG Price Increase for December – SUCH TV



The Oil and Gas Regulatory Authority (OGRA) has approved a fresh increase in the price of liquefied petroleum gas (LPG), raising the cost for both domestic consumers and commercial users.

According to the notification issued, the LPG price has been increased by Rs7.39 per kilogram, setting the new rate at Rs209 per kg for December. As a result, the price of a domestic LPG cylinder has risen by Rs87.21, bringing the new price to Rs2,466.10.

In November, the price of LPG stood at Rs201 per kg, while the domestic cylinder was priced at Rs2,378.89.

The latest price hike is expected to put additional pressure on households already grappling with rising living costs nationwide.



Source link

Continue Reading

Trending